Monday 11 April 2016

• 17:00 - Innovation in Immunotherapy
  Professor Paresh Vyas (University of Oxford, Weatherall Institute of Molecular Medicine), Prof Vincenzo Cerundolo (MRC Human Immunology Unit, WIMM, University of Oxford), Dr Bent Jakobsen (Chief Scientific Officer, Immunocore), Martin Pule (Cancer Institute, UCL), Dr Robert Wilkinson (Director of Oncology Research, MedImmune Ltd), Prof Sarah Gilbert (Professor of Vaccinology at Oxford University, Founder of Vaccitech), Dr Eliot Forster (CEO of Immunocore Ltd), Dr Lucinda Crabtree (Senior Investment Analyst, Woodford Investment Management LLP), Prof Mark Middleton (Lead Cancer Clinician for the Oxford University Hospitals NHS Foundation Trust and deputy director of the Cancer Research UK Oxford Centre)